Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Pulmonology

  • 1
    News

    Vaping-linked lung injuries near 1,500

    October 17, 2019

    Seventy percent of patients are male, and 79% are under age 35 years.

  • 1
    News

    FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients

    October 15, 2019

    The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.

  • News

    No clear benefit from conservative oxygen in mechanical ventilation

    October 14, 2019

    Using conservative oxygen therapy in adults undergoing mechanical ventilation in the ICU does not increase ventilation-free days.

  • 1
    News

    CDC updates guidance on vaping-associated lung injury

    October 11, 2019

    “We are not seeing a drop in cases” but a continuation of the trend of hospitalization and deaths that started in August 2019.

  • 1
    News

    Influenza vaccination modestly reduces risk of hospitalizations in patients with COPD

    October 9, 2019

    Older patients with COPD need more effective influenza vaccines and other preventive strategies.

  • 1
    News

    Histologic analysis of vaping-associated lung injury suggests chemical pneumonitis

    October 4, 2019

    Foamy macrophages and pneumocyte vacuolization were seen in all cases.

  • 1
    News

    Vaping-associated lung injury cases exceed 1,000

    October 3, 2019

    As of Oct. 1, there have been 1,080 confirmed and probable cases of lung injury associated with the use of e-cigarettes, or vaping.

  • News

    Lefamulin found noninferior to moxifloxacin for bacterial pneumonia

    October 1, 2019

    Oral lefamulin, the first pleuromutilin antibiotic approved for intravenous and oral administration, was noninferior to oral moxifloxacin for inducing an early clinical response in patients with bacterial pneumonia, acording to data from a global multicenter study of 738 individuals.

  • 1
    News

    Vitamin C infusion falls short for sepsis and ARDS patients

    October 1, 2019

    Vitamin C failed to improve organ dysfunction, inflammation, or vascular injury in adults with sepsis and ARDS.

  • 1
    News

    Caution with IVC filters in elderly

    September 30, 2019

    Are inferior vena cava (IVC) filters in older adults safe for prevention of subsequent pulmonary embolism (PE)?

Previous1 … 37 38 39 40 41 … 60Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • Cookie Preferences